Sign In
Buy ZBH
$84.98
+1.23 (+1.47%)
At Close: Jun 03, 2026
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results
07:30am, Friday, 03'rd Oct 2025
WARSAW, Ind. , Oct. 3, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 a
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
11:16am, Thursday, 02'nd Oct 2025
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
10:41am, Thursday, 02'nd Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ZBH vs. ESLOY: Which Stock Is the Better Value Option?
12:40pm, Monday, 29'th Sep 2025
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best opti
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
09:21am, Monday, 29'th Sep 2025
The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in hospitals, and a shift toward minimally invasive procedures. As of 2025, it'
Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System
04:30pm, Thursday, 25'th Sep 2025
iTaperloc® Complete and iG7™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint I
All You Need to Know About Zimmer (ZBH) Rating Upgrade to Buy
01:01pm, Monday, 22'nd Sep 2025
Zimmer (ZBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Zimmer Biomet (ZBH) Stock Undervalued Right Now?
10:40am, Wednesday, 17'th Sep 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
10:40am, Monday, 15'th Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ZBH or ESLOY: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 12'th Sep 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks present
Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
05:47pm, Monday, 08'th Sep 2025
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 8:30 AM EDT Company Participants Ivan Tornos - President, CEO & Chairman of the Board
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
04:05pm, Thursday, 04'th Sep 2025
WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
10:41am, Friday, 29'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Add Zimmer Biomet Stock to Your Portfolio Now?
09:15am, Thursday, 28'th Aug 2025
ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
07:30am, Thursday, 28'th Aug 2025
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M.
